These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2501255)
1. In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen. Tanaka T; Suzuki S; Masuko T; Hashimoto Y Jpn J Cancer Res; 1989 Apr; 80(4):380-6. PubMed ID: 2501255 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of anti-c-erbB-2 immunoliposomes containing doxorubicin on human cancer cells. Suzuki S; Uno S; Fukuda Y; Aoki Y; Masuko T; Hashimoto Y Br J Cancer; 1995 Sep; 72(3):663-8. PubMed ID: 7669578 [TBL] [Abstract][Full Text] [Related]
3. Endocytosis does not necessarily augment the cytotoxicity of adriamycin encapsulated in immunoliposomes. Suzuki S; Watanabe S; Uno S; Tanaka M; Masuko T; Hashimoto Y Biochim Biophys Acta; 1994 Dec; 1224(3):445-53. PubMed ID: 7803502 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies. Ohta S; Igarashi S; Honda A; Sato S; Hanai N Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645 [TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Ahmad I; Allen TM Cancer Res; 1992 Sep; 52(17):4817-20. PubMed ID: 1511445 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer. Yu DS; Chu TM; Yeh MY; Chang SY; Ma CP; Han SH J Urol; 1988 Aug; 140(2):415-21. PubMed ID: 3398165 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody. Hashimoto Y; Sugawara M; Masuko T; Hojo H Cancer Res; 1983 Nov; 43(11):5328-34. PubMed ID: 6616468 [TBL] [Abstract][Full Text] [Related]
8. Basic approach to application of chemoimmunoliposomes for cancer therapy. Hashimoto Y; Sugawara M; Kamiya T; Suzuki S; Tanaka T; Hojo H NCI Monogr; 1987; (3):89-94. PubMed ID: 3821923 [TBL] [Abstract][Full Text] [Related]
9. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells. Nam SM; Kim HS; Ahn WS; Park YS Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027 [TBL] [Abstract][Full Text] [Related]
10. Appearance of a proliferation-associated antigen, gp125, on rat and human lymphocytes by co-stimulation with phorbol ester and calcium ionophore. Tanaka T; Masuko T; Hashimoto Y J Biochem; 1988 Apr; 103(4):644-9. PubMed ID: 3139647 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor cell growth in vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and humans. Yagita H; Masuko T; Hashimoto Y Cancer Res; 1986 Mar; 46(3):1478-84. PubMed ID: 2417704 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Lopes de Menezes DE; Pilarski LM; Allen TM Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662 [TBL] [Abstract][Full Text] [Related]
13. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells. Masuko T; Abe J; Yagita H; Hashimoto Y Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of adriamycin entrapped in liposomes conjugated with monoclonal antibody against tumor-associated antigen of bovine leukemia cells. Onuma M; Odawara T; Watarai S; Aida Y; Ochiai K; Syuto B; Matsumoto K; Yasuda T; Fujimoto Y; Izawa H Jpn J Cancer Res; 1986 Nov; 77(11):1161-7. PubMed ID: 3025145 [TBL] [Abstract][Full Text] [Related]
15. [Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors]. Konno H; Kumai K; Tsubouchi T; Ishibiki K; Abe O; Tadakuma T; Yasuda T; Nagaike K; Hosokawa S; Sakaguchi S Gan To Kagaku Ryoho; 1989 Jun; 16(6):2213-7. PubMed ID: 2472119 [TBL] [Abstract][Full Text] [Related]
16. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposomes and adriamycin]. Li WJ; Qian HN; Lu WY Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):539-41, 582. PubMed ID: 7842351 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods. Sinkule JA; Rosen ST; Radosevich JA Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554 [TBL] [Abstract][Full Text] [Related]
18. Immunochemical and biochemical characterizations of two monoclonal antibody-reacting antigens associated with human bladder carcinoma. Zhang DS; Lin CW Cancer Res; 1989 Dec; 49(23):6621-8. PubMed ID: 2819713 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytes. Yagita H; Hashimoto Y J Immunol; 1986 Mar; 136(6):2062-8. PubMed ID: 2419421 [TBL] [Abstract][Full Text] [Related]
20. Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin. Lundberg BB; Griffiths G; Hansen HJ Int J Pharm; 2000 Sep; 205(1-2):101-8. PubMed ID: 11000546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]